CTEK yields 160.00% · JNJ yields 2.13%● Live data
📍 CTEK pulled ahead of the other in Year 1
Combined, CTEK + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTEK + JNJ for your $10,000?
CynergisTek, Inc. provides cyber security, privacy, and compliance services in the United States. The company identifies, measures, and tests security and privacy risk of organization, as well as verifies and validates their programs to meet compliance and business objectives through IT audits, technical testing, and risk and program assessments; develops policies, procedures, and playbooks to help build out a risk management program; and verifies the processes, people, and technology are working effectively. It also provides insights to the ROI of an organization's security investment; resources to help organizations prioritize, implement, and execute initiatives to strengthen their security and privacy programs; and on-going management and oversight organization's security and privacy programs to address or give alerts when an issue arises. It serves primarily in the healthcare industry, as well as education, financial services, government, internet and media, and manufacturing industries under the CynergisTek, Redspin, and Backbone Consulting brands. The company was formerly known as Auxilio, Inc. and changed its name to CynergisTek, Inc. in September 2017. CynergisTek, Inc. was incorporated in 1995 and is based in Austin, Texas.
Full CTEK Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.